Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000546473 | SCV000648164 | likely benign | Rhabdoid tumor predisposition syndrome 2 | 2024-11-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000572455 | SCV000672104 | likely benign | Hereditary cancer-predisposing syndrome | 2016-04-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV001809548 | SCV002058006 | likely benign | Intellectual disability, autosomal dominant 16 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000572455 | SCV002535226 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-11-12 | criteria provided, single submitter | curation |